As respiratory allergic diseases are characterized by a late-phase immune response in which, Th2 cells recognizing common airborne antigens produce an inflammatory response with some Th2 cytokines IL-4, IL-5, and IL-13, this extra-supplementation in westernised countries might influence the allergy epidemic. Here, IL13 is linked to allergic respiratory disease.